Transfer factors are tiny protein fragments produced by immune cells that carry information about threats your immune system has encountered. Weighing less than 5,000 daltons (far smaller than antibodies, which range from 150,000 to 970,000 daltons), these molecules can pass immune “memory” from one organism to another, essentially teaching a naive immune system to recognize specific pathogens without prior exposure.
American immunologist Henry Sherwood Lawrence discovered transfer factors in 1949 at New York University. He found that injecting a small extract from the white blood cells of a person who had immunity to tuberculosis could transfer that same immune reactivity to someone who had never been exposed. This was a new category of immune communication, distinct from antibodies.
How Transfer Factors Work
Your immune system has two main branches: the antibody-driven side (which tags invaders for destruction) and the cell-mediated side (which directly kills infected cells). Transfer factors operate on the cell-mediated side. They are low-molecular-weight fragments released by T cells, a type of white blood cell, and they carry enough molecular detail to help other immune cells recognize a specific pathogen.
When a recipient receives transfer factors, their immune cells gain the ability to mount what’s called delayed-type hypersensitivity, a targeted inflammatory response against a particular threat. This is unusual because it shares features of both passive immunity (transferred, not self-generated) and active immunity (the recipient’s own cells carry out the response). In animal studies, administration of transfer factors triggered a 77-fold increase in interferon-gamma, a signaling molecule that promotes antiviral activity, and a 26-fold increase in interleukin-6, which helps coordinate immune responses. These changes appeared within 24 hours.
Researchers have identified two opposing functional components within transfer factor extracts. One fraction acts as an inducer, amplifying immune responses against a specific antigen. The other acts as a suppressor, dialing responses down. Both are antigen-specific and dose-dependent, which means the extract doesn’t simply rev up the immune system across the board. It can, in theory, boost a weak response while restraining an overactive one. This dual capability is part of what makes transfer factors interesting to immunologists, even though their precise chemical structure and molecular mechanism remain incompletely defined.
Where Transfer Factors Come From
Transfer factors were originally extracted from human white blood cells, which limited their practical use. Today, the two main commercial sources are bovine colostrum (the first milk produced by cows after giving birth) and chicken egg yolks. Both contain immune molecules that can be filtered down to the small peptide sizes associated with transfer factor activity.
Bovine colostrum is rich in immunoglobulins, antimicrobial peptides, and other bioactive molecules that influence both branches of the immune system, including B cells, T cells, natural killer cells, and macrophages. When processed through ultrafiltration and nanofiltration, the resulting extract contains bioactive products smaller than 10,000 daltons, concentrating the transfer factor fraction while removing the much larger antibodies.
One notable property of bovine colostrum extracts is their apparent ability to modulate immune responses in both directions. Research on human immune cells showed that bovine colostrum enhanced interferon-gamma production when the immune stimulus was weak (as with cytomegalovirus) but suppressed the same molecule when the stimulus was strong. This suggests a balancing effect rather than simple stimulation.
It is also possible to produce pathogen-specific transfer factors. Researchers have created extracts targeted to particular organisms, such as Staphylococcus aureus, by immunizing the source animal against that pathogen before harvesting the transfer factors.
How Transfer Factors Differ From Antibodies
Antibodies are large Y-shaped proteins produced by B cells. They circulate in the blood, latch onto invaders, and mark them for destruction. Transfer factors are fundamentally different. They are far smaller (under 5,000 daltons versus 150,000 or more for antibodies), they come from T cells rather than B cells, and they don’t attack pathogens directly. Instead, they pass along recognition information so the recipient’s own immune cells can mount a targeted cell-mediated response.
Structurally, transfer factors have high levels of the amino acids tyrosine and glycine and share similarities with certain brain signaling molecules in the enkephalin family. They can be purified to a high degree of homogeneity, but researchers still lack a complete picture of their exact chemical identity, which has been a persistent challenge in the field.
Conditions Studied
Transfer factors have been investigated as both a standalone and an add-on therapy for a range of immune-related conditions. The list includes viral, bacterial, fungal, and parasitic infections, as well as immunodeficiencies, certain cancers, allergies, and autoimmune diseases. Most of this research has been conducted in small clinical studies or animal models rather than large-scale trials.
Herpes family viruses stand out as a particularly responsive category. Studies have reported that transfer factors can prevent initial infection or reduce relapse in conditions caused by these viruses, functioning in some cases like a cell-mediated immunity vaccine. For shingles specifically, transfer factors have been administered as injections under the skin, given daily for seven days in adults. In children, a single weight-based dose targeting the varicella virus has been studied.
In tuberculosis research, transfer factors have been tested as a complement to standard drug treatment, with results suggesting they can enhance or correct cell-mediated immune responses against the bacteria.
Oral Supplements and Absorption
Most transfer factor products sold today are oral supplements derived from bovine colostrum, egg yolk, or a combination. A reasonable question is whether these small peptides survive digestion. Their low molecular weight actually works in their favor here. Molecules under 10,000 daltons are small enough to interact with gut-associated immune tissue, and safety profiling of oral transfer factor products has confirmed them as safe for oral use with potential immune system benefits.
That said, the oral route delivers transfer factors differently than injection. The original research by Lawrence and decades of clinical studies used injectable preparations derived from human white blood cells. Oral supplements from animal sources represent a different product category, and the evidence base for the two delivery methods is not interchangeable.
Safety and Regulatory Status
Animal studies with colostrum and egg yolk-derived transfer factors have reported no clinical signs of illness, and the immune effects observed have been relatively targeted rather than causing widespread inflammatory activation. If you have a dairy or egg allergy, however, the source material is worth considering, since these products are derived from bovine colostrum or chicken egg yolks.
In the United States, transfer factor products are classified as dietary supplements, not drugs. This means they are not evaluated by the FDA for effectiveness before reaching store shelves. They must follow supplement labeling rules, including proper identification as a dietary supplement, correct serving size declarations, and compliant nutrition facts panels. A 2025 FDA warning letter to one manufacturer cited multiple labeling violations on its transfer factor product, highlighting that regulatory oversight focuses on manufacturing and labeling compliance rather than clinical efficacy claims.
Because transfer factors remain incompletely characterized at the molecular level, there is no standardized potency measure across products. Two supplements labeled “transfer factors” may contain quite different compositions depending on the source animal, the immunization protocol (if any), and the filtration process used during manufacturing.